Literature DB >> 4361687

DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma.

M Nonoyama, C H Huang, J S Pagano, G Klein, S Singh.   

Abstract

The association of Epstein-Barr virus (EBV) DNA with African tumors was examined by the method of hybridization with complementary RNA. 22 out of 23 biopsies of Burkitt's lymphoma and 18 out of 23 biopsies of nasopharyngeal carcinoma were found to contain EBV DNA. The number of EBV genome equivalents per cell ranged from four to 113. Five out of 24 other African tumors, two adenocarcinomas, and one each of melanoma, reticulum cell sarcoma, and carcinoma of the antrum, also contained EBV DNA.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4361687      PMCID: PMC427213          DOI: 10.1073/pnas.70.11.3265

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  9 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

3.  Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.

Authors:  G Miller; J C Niederman; L L Andrews
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

4.  Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics.

Authors:  M Nonoyama; J S Pagano
Journal:  Nature       Date:  1973-03-02       Impact factor: 49.962

5.  EB-virus associated serology in malignant disease: antibody levels to viral capsid antigens (VCA), membrane antigens (MA) and early antigens(EA) in patients with various neoplastic conditions.

Authors:  A De Schryver; G Klein; G Henle; W Henle; H M Cameron; L Santesson; P Clifford
Journal:  Int J Cancer       Date:  1972-03-15       Impact factor: 7.396

6.  Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.

Authors:  G Henle; W Henle; G Klein
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

7.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

8.  EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx.

Authors:  H zur Hausen; H Schulte-Holthausen; G Klein; W Henle; G Henle; P Clifford; L Santesson
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

9.  Selective thrombocytopenia due to localised microangiopathy of renal allografts.

Authors:  V K Pillay; N A Kurtzman; J R Manaligod; O Jonasson
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

  9 in total
  42 in total

1.  The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.

Authors:  C T Lin; C R Lin; G K Tan; W Chen; A N Dee; W Y Chan
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.

Authors:  P Busson; R McCoy; R Sadler; K Gilligan; T Tursz; N Raab-Traub
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases.

Authors:  C H Tsai; M V Williams; R Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

Authors:  A L Epstein; W Henle; G Henle; J F Hewetson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

Review 5.  Oncogenic properties of human viruses.

Authors:  R Glaser; B Decker; F Rapp
Journal:  In Vitro       Date:  1975 May-Jun

6.  Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens.

Authors:  T C Wu; R B Mann; J I Epstein; E MacMahon; W A Lee; P Charache; S D Hayward; R J Kurman; G S Hayward; R F Ambinder
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 7.  Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.

Authors:  Javier S Burgos
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

8.  EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.

Authors:  N S Sung; S Kenney; D Gutsch; J S Pagano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  Infectious mononucleosis and mononucleosis syndromes.

Authors:  M Fiala; D C Heiner; J A Turner; B Rosenbloom; L B Guze
Journal:  West J Med       Date:  1977-06

10.  Vaccination against EB virus.

Authors: 
Journal:  Br Med J       Date:  1976-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.